Centers

VMCC, University of Michigan

FDA Oncology Center of Excellence Project Catalyst

EU-OPENSCREEN


The VMCC is an on-campus core facility for the design and synthesis of drug-like molecules and diagnostic probes used in biomedical investigations.

Our Mission: To assist biomedical researchers in translating novel therapeutic hypotheses into...
Read more

Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation

Read more
EU-OPENSCREEN is a multinational, not-for-profit initiative, which integrates high-capacity screening platforms and chemistry groups across Europe. The aim of this initiative is to support individual scientists interested in chemical biology...
Read more

Partnerships

Events

Jobs

Eisiai Partners with Johns Hopkins Brain Science Institute

Eisiai Partners with Johns Hopkins Brain Science Institute ("BSi") an institute which is part of Johns Hopkins University to develop new drugs for neurological diseases. Under this joint collaboration, BSi will provide validated targets to Eisai...

 
View all

Cerecor Partners with Johns Hopkins Brain Science Institute to Treat Schizophrenia

Cerecor a Baltimore based company has taken an option with Johns Hopkins University to license D-Amino Acid Oxidase inhibitors (DAAO) to treat Schizophrenia. The DAAO inhibitor molecules are currently being developed by researchers at the Johns...

 
View all

CWHM/OWH Childhood Diarrhea

CWHM signed a joint research agreement in 2010 with the Institute for One World Health to discover and develop new drugs to combat diarrhea, which is the second leading cause of death worldwide in children under age 5. Under the agreement, CWHM...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All